- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Urothelial Neoplasm
Total 107317 results
-
Kyowa Kirin, Inc.TerminatedUrothelial CarcinomaUnited States, Spain
-
Incyte CorporationTerminatedUrothelial CarcinomaUnited States, France, Italy
-
AEterna ZentarisUniversity of Miami; University of Miami Sylvester Comprehensive Cancer Center and other collaboratorsTerminatedUrothelial CarcinomaUnited States
-
National Taiwan University HospitalUnknownUrothelial CarcinomaTaiwan
-
Peking University First HospitalPeking University First Hospital Miyun HospitalNot yet recruiting
-
Xuesong LiRecruitingUrothelial Carcinoma Ureter | Locally AdvancedChina
-
Leonard ApplemanSanofi-SynthelaboCompletedMetastatic Transitional Cell Cancer of the Urothelial TractUnited States
-
Yung NAQueen Mary Hospital, Hong Kong; Pamela Youde Nethersole Eastern HospitalRecruitingMuscle-Invasive Bladder Carcinoma | Muscle Invasive Bladder Urothelial CarcinomaHong Kong
-
University of Michigan Rogel Cancer CenterCelgene CorporationTerminatedBladder Cancer | Urothelial CancerUnited States
-
Latin American Cooperative Oncology GroupJanssen-Cilag Ltd.CompletedClinical-pathological Characterization and Outcomes of Metastatic Urothelial Cancer in Latin AmericaRecurrent/Metastatic Urothelial CancersBrazil
-
RenJi HospitalRecruitingUpper Urinary Tract Urothelial Carcinoma | Kidney Preservation | HER-2 ADC | PD-1antibodyChina
-
Memorial Sloan Kettering Cancer CenterMerck Sharp & Dohme LLC; Astellas Pharma US, Inc.; Seagen Inc.RecruitingUrothelial CarcinomaUnited States
-
PfizerMerck KGaA, Darmstadt, GermanyActive, not recruiting
-
The Netherlands Cancer InstituteBristol-Myers SquibbCompletedUrothelial CarcinomaNetherlands
-
Daiichi Sankyo, Inc.Bristol-Myers Squibb; AstraZenecaActive, not recruitingBreast Cancer | Urothelial CarcinomaUnited States, Spain, Italy, Belgium, France, Germany, United Kingdom
-
DendreonTerminatedUrothelial CarcinomaUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)WithdrawnStage II Bladder Urothelial Carcinoma
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingTransitional Cell Carcinoma | Metastatic Urothelial Carcinoma | Unresectable Transitional Cell CarcinomaUnited States
-
Kinnate BiopharmaActive, not recruitingIntrahepatic Cholangiocarcinoma | Urothelial Carcinoma | Solid Tumor, AdultUnited States, Korea, Republic of, Taiwan, China, Denmark, Spain
-
Incyte CorporationAstraZenecaCompletedHead and Neck Cancer | Lung Cancer | Solid Tumors | UC (Urothelial Cancer)United States
-
National Cancer Institute (NCI)RecruitingLung Neoplasms | Small Cell Lung Cancer | Prostate Cancer | Urothelial Carcinoma | Urothelial CancerUnited States
-
Beijing Huanxing Cancer HospitalNewish Technology (Beijing) Co., Ltd.TerminatedUrinary Bladder NeoplasmChina
-
UroGen Pharma Ltd.TerminatedBladder Cancer | Urothelial Carcinoma Bladder | Urothelial CarcinomaUnited States, Israel, Russian Federation, Georgia, Bulgaria, Estonia, Latvia, Poland, Serbia, Ukraine
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyNot yet recruitingUrothelial CarcinomaUnited States, Germany
-
Seagen Inc.Merck Sharp & Dohme LLC; RemeGen Co., Ltd.RecruitingUrothelial CarcinomaUnited States, Canada, Australia, Singapore
-
Seagen Inc.RecruitingUrothelial CarcinomaUnited States, France
-
Seagen Inc.Merck Sharp & Dohme LLCRecruitingUrothelial CarcinomaUnited States, Canada, United Kingdom, Japan, Australia, Argentina, Chile, Israel
-
BayerActive, not recruitingUrothelial CarcinomaUnited States, Korea, Republic of, Japan, Germany, Italy, Spain, Austria, France
-
Hoffmann-La RocheCompletedUrothelial CarcinomaSpain, United States, Korea, Republic of, Canada, United Kingdom, Czechia, Australia, Belgium, Brazil, China, Estonia, Finland, Greece, Hong Kong, Italy, Poland, Portugal, Slovenia, Mexico, Georgia, Russian Federation, Singapore, Th... and more
-
University of OklahomaEMD Serono; Aravive, Inc.Active, not recruitingUrothelial CarcinomaUnited States
-
Basilea PharmaceuticaCompletedUrothelial CarcinomaUnited Kingdom, Korea, Republic of, Italy, Canada, France, Spain, Germany, United States, Hungary, Australia, Poland, Switzerland, Czechia, Austria
-
Eli Lilly and CompanyCompletedUrothelial CarcinomaSpain, United States, Poland, Romania, Taiwan, Ukraine, Netherlands, Mexico, Japan, France, Germany, Belgium, Greece, Russian Federation, Turkey, Canada, Israel, Italy, United Kingdom, Denmark, Korea, Republic of, Australia, Hungary
-
Fox Chase Cancer CenterStand Up To Cancer; Van Andel Research InstituteActive, not recruitingUrothelial CarcinomaUnited States
-
University of Colorado, DenverAmgenWithdrawnUrothelial Carcinoma
-
Vyriad, Inc.Mayo ClinicCompletedUrothelial CarcinomaUnited States
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNot yet recruiting
-
Chunguang yang (101937)RecruitingUrothelial Carcinoma | Radical CystectomyChina
-
Ho Kyung SeoNot yet recruiting
-
Hoffmann-La RocheGilead Sciences, Inc., GlaxoSmithKline plc, Seattle Genetics and AstellasRecruitingBladder Cancer | Urothelial CarcinomaUnited States, Spain, Korea, Republic of, United Kingdom, Taiwan, France, Greece
-
Indiana UniversityTerminatedProstate Cancer | Urothelial CarcinomaUnited States
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingBladder Cancer | Non-Muscle-Invasive Urothelial CarcinomaUnited States
-
Rigshospitalet, DenmarkOdense University Hospital; Danish Cancer Society; Herlev Hospital; Aalborg University...Completed
-
Matthew GalskyMerck Sharp & Dohme LLC; Hoosier Cancer Research NetworkCompletedBladder Cancer | Urothelial CarcinomaUnited States
-
University of Michigan Rogel Cancer CenterGlaxoSmithKlineWithdrawnBladder Cancer | Urothelial CancerUnited States
-
British Urology Researchers in Surgical TrainingAction Bladder Cancer UK; The Urology Foundation; Test Evaluation Research Group...CompletedUrothelial CarcinomaUnited Kingdom
-
Guarionex J. DecastroSanofiActive, not recruitingUrothelial Carcinoma of the Urinary BladderUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)TerminatedStage III Renal Cell Cancer | Recurrent Bladder Carcinoma | Stage I Prostate Cancer | Stage III Prostate Cancer | Infiltrating Bladder Urothelial Carcinoma | Stage II Bladder Urothelial Carcinoma | Stage IIA Prostate Cancer | Stage IIB Prostate Cancer | Stage I Renal Cell Cancer | Stage II Renal Cell CancerUnited States
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNanfang Hospital of Southern Medical University; The Third Affiliated Hospital... and other collaboratorsNot yet recruiting
-
National Cancer Center, KoreaSamsung Medical Center; Asan Medical Center; Seoul National University Hospital; Korea University Anam Hospital and other collaboratorsRecruitingUrothelial CarcinomaKorea, Republic of
-
Jens NielsenGöteborg UniversityCompletedBladder CancerSweden